Alere Inc. (ALR)


NYSE - NYSE Real Time Price. Currency in USD
39.53-1.16 (-2.85%)
At close: 4:00 PM EDT
People also watch:
BIOHOLXHAEDXCMCRL
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open40.77
Prev Close40.69
Bid39.57 x 200
Ask39.60 x 200
Day's Range38.80 - 42.12
52wk Range31.47 - 54.79
1y Target EstN/A
Market Cap3.43B
P/E Ratio (ttm)-95.95
Beta-0.29
Volume1,422,545
Avg Vol (3m)1,039,695
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • American City Business Journals21 minutes ago

    Alere sues Abbott to complete $5.8B merger

    Shares of Waltham-based diagnostics firm Alere fell 4 percent on Friday afternoon after the company issued a statement saying it’s suing the company it’s hoping to merge with, Abbott Laboratories. Illinois-based Abbott (ABT) announced an agreement to buy Alere on Feb. 1 for $5.8 billion, but the deal quickly ran into problems.

  • The Wall Street Journal2 hours ago

    [$$] Alere Sues Abbott to Force Merger

    Alere Inc. escalated its fight with reluctant buyer Abbott Laboratories by filing a lawsuit against its potential acquirer to push it to move forward with the deal.

  • Reuters2 hours ago

    Alere sues Abbott over $5.8 bln takeover

    Diagnostic-testing company Alere Inc said on Friday it sued Abbott Laboratories in an attempt to force the company to move ahead with its $5.8 billion takeover of Alere. Alere said the lawsuit seeks to compel Abbott to obtain all the antitrust approvals it needs to complete the deal. It said the complaint was filed Thursday in Delaware Chancery Court yesterday and should be made publicly available next week.